SCHEMBL9252849

SCHEMBL9252849

[CH2]c1cc(NCc2cc(O)ccc2O)ccc1O

nearest known ligand 0.72

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.72
RGS12 O14924 1/20 0.61
ALDH1A1 P00352 1/20 0.61
LCK P06239 1/20 0.61
MAPT P10636 1/20 0.61
CAMKK2 Q96RR4 1/20 0.61
NOX4 Q9NPH5 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
HKDC1 Q2TB90 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9163440 0.84 EGFR (1.00) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL9248938 0.81 EGFR (0.63) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL10172851 0.80 EGFR (0.72) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL11510755 0.79 EGFR (0.71) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL2989135 0.78 EGFR (0.80) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL11981619 0.77 EGFR (0.79) EGFRRGS12ALDH1A1LCKMAPT
Hydrochloric Acid SCHEMBL2992201 0.77 EGFR (0.77) EGFRRGS12ALDH1A1LCKMAPT
Lavendustin C SCHEMBL30569227 0.76 EGFR (1.00) EGFRRGS12ALDH1A1LCKMAPT
Lavendustin C SCHEMBL1821516 0.76 EGFR (1.00) EGFRRGS12ALDH1A1LCKMAPT
SCHEMBL7809216 0.75 EGFR (0.81) EGFRRGS12ALDH1A1LCKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0641311-A1 NOVEL DIHYDROXYBENZYLAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 1995-03-08 EP disclosed
WO-1993023364-A1 NOVEL DIHYDROXYBENZYLAMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1993-11-25 WO disclosed